Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855094) titled 'Wavelight Plus Sightmap-LASIK vs. Wavefront-Optimized-LASIK' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: 59th Medical Wing
Condition:
Myopia
Astigmatism
Intervention:
Procedure: LASIK calculated ablation using Wavefront-Optimized
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 6, 2026
Target Sample Size: 49
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07...